Back to Search
Start Over
Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 years.
Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 years.
- Source :
-
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA [Knee Surg Sports Traumatol Arthrosc] 2020 Apr; Vol. 28 (4), pp. 1130-1143. Date of Electronic Publication: 2020 Jan 02. - Publication Year :
- 2020
-
Abstract
- Purpose: The aim of this study was to investigate the effect of product dose in autologous chondrocyte implantation (ACI) for the treatment of full-thickness cartilage defects of the knee and to assess its influence on clinical and morphological mid-term outcome.<br />Methods: Seventy-five patients were included in this single-blind, randomised, prospective, controlled clinical trial. Patients were assigned randomly to three different dose groups [low (3-7 spheroids/cm <superscript>2</superscript> ), medium (10-30 spheroids/cm <superscript>2</superscript> ), or high (40-70 spheroids/cm <superscript>2</superscript> )] and assessed using standardised clinical and morphological scoring systems (KOOS, IKDC, MOCART) for 4 years following the intervention.<br />Results: The analysis population comprised 75 patients (22 women, 53 men) aged 34 ± 9 years. Defect sizes ranged from 2 to 10 cm <superscript>2</superscript> following intraoperative debridement. The assessment of the primary variable 'overall KOOS' showed a statistically significant improvement, compared with baseline, for each dose group, i.e., at baseline the mean 'overall KOOS' scores were 60.4 ± 13.6, 59.6 ± 15.4, and 51.1 ± 15.4 for the low-, medium-, and high-dose groups, respectively, and 57.0 ± 15.2 for 'all patients'. After 48 months those values improved to 80.0 ± 14.7, 84.0 ± 14.9, and 66.9 ± 21.5 in the respective dose groups and 77.1 ± 18.6 for 'all patients'. Pairwise comparisons of these dose groups did not reveal any statistically significant differences. Likewise, assessment of the subjective IKDC score revealed no statistically significant differences between the three dose groups up to the 48-month visit. However, between 12 and 48 months there was a low, but steady, improvement in the low-dose group and a substantial amelioration in the medium-dose group. The mean MOCART total scores 3 months after treatment were 59.8 ± 10.9, 64.5 ± 10.3, and 64.7 ± 9.4 for the low-, medium-, and high-dose groups, and 62.9 ± 10.3 for 'all patients'; 48 months after treatment these were 73.9 ± 13.1, 78.0 ± 12.4, and 74.3 ± 14.0 for the respective dose groups and 75.5 ± 13.1 for 'all patients'.<br />Conclusions: Results of this study confirm the efficacy and safety of the applied "advanced therapy medicinal product"; no dose dependence was found either for the incidence or for the severity of any adverse reactions. All doses applied in the present study led to significant clinical improvement over time and can therefore be regarded as effective doses. The influence of product doses in the range investigated seems to be low and can be neglected. Thus, the authorised dose range of 10-70 spheroids/cm <superscript>2</superscript> confirmed by this clinical trial offers a broad therapeutic window for the surgeon applying the product, thereby reducing the risk of over- or underdosing.<br />Level of Evidence: I.
- Subjects :
- Adolescent
Adult
Female
Humans
Male
Middle Aged
Postoperative Complications
Prospective Studies
Single-Blind Method
Transplantation, Autologous
Young Adult
Cartilage Diseases surgery
Cartilage, Articular surgery
Chondrocytes transplantation
Knee Joint surgery
Orthopedic Procedures adverse effects
Orthopedic Procedures methods
Subjects
Details
- Language :
- English
- ISSN :
- 1433-7347
- Volume :
- 28
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
- Publication Type :
- Academic Journal
- Accession number :
- 31897548
- Full Text :
- https://doi.org/10.1007/s00167-019-05786-8